Study of a new compound that is being developed for the treatment of Rheumatoid Arthritis and other auto-immune diseases
You will receive a gross compensation of € 1.414,- for participation in part B of this study.
Travelling expenses will be reimbursed based on the distance traveled (€0,19 net per kilometer) with a minimum of €12,- and a maximum of €160,- (840 kilometers) per return, regardless of the mode of transportation.
Period of stay and research
For part B, the study consists of 2 periods during which you will stay in our research facility in Groningen, location UMCG for 4 days (3 nights). Period 1 will be followed by 2 short visits and Period 2 will be followed by 3 short visits.
Please note: You have to be available for all dates for the group of choice to be able to participate in this study. These are the currently planned dates; however, these may be subject to change.
Sign up for one of the following study groups
2× 4 days stay
- 21 Nov 2017 up to and including 24 Nov 2017
- 5 Dec 2017 up to and including 8 Dec 2017
- 26 Nov 2017
- 29 Nov 2017
- 10 Dec 2017
- 13 Dec 2017
- 20 Dec 2017